Immune Diseases Clinical Trials

2 recruiting

Immune Diseases Trials at a Glance

97 actively recruiting trials for immune diseases are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Beijing, Hangzhou, and Wuhan. Lead sponsors running immune diseases studies include Peking Union Medical College Hospital, The Children's Hospital of Zhejiang University School of Medicine, and Tongji Hospital.

Browse immune diseases trials by phase

Treatments under study

About Immune Diseases Clinical Trials

Looking for clinical trials for Immune Diseases? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Immune Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Immune Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 97 trials

Recruiting

Deciphering the Genetic Architecture of Autoimmune Diseases

Autoimmune Diseases
National Human Genome Research Institute (NHGRI)300 enrolled2 locationsNCT06948110
Recruiting
Phase 1

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company125 enrolled28 locationsNCT07115745
Recruiting

The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

VasculitisSystemic Lupus Erthematosus (SLE)Rheumatic Diseases+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre100 enrolled1 locationNCT07278609
Recruiting
Not Applicable

Study on the Clinical Efficacy of Transcranial Strong Alternating Current (Hi-tACS) in Patients With Neuroimmune Diseases With Insomnia

Neuroimmune Diseases With Insomnia
Xuanwu Hospital, Beijing80 enrolled1 locationNCT07558616
Recruiting
Not Applicable

Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease

Celiac DiseaseAutoimmune DiseasesGluten Sensitivity
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud51 enrolled1 locationNCT07362654
Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Healthy ParticipantsHealthy VolunteersAutoimmune Diseases+1 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Not Applicable

CAR-T Therapy for Refractory Autoimmune Diseases

Autoimmune Diseases
LiangZou20 enrolled1 locationNCT07059169
Recruiting
Phase 1Phase 2

Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT06435897
Recruiting
Not Applicable

Testimonials and Navigation in Rheumatology

Autoimmune DiseasesRheumatologic Disease
University of Alabama at Birmingham1,170 enrolled3 locationsNCT06469788
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting
Not Applicable

Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement

Autoimmune Diseases
Peking Union Medical College Hospital60 enrolled1 locationNCT05789030
Recruiting
Early Phase 1

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07507201
Recruiting
Not Applicable

Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project

Inflammatory ArthritisRare Auto-immune DiseasesImmune Checkpoint Inhibitor Related Inflamamtory Arthritis
University Hospital, Brest100 enrolled2 locationsNCT07302074
Recruiting
Early Phase 1

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

Autoimmune Diseases
Ruijin Hospital66 enrolled3 locationsNCT06747156
Recruiting

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

CancerMetabolic DiseaseChronic Kidney Diseases+3 more
University Hospital, Toulouse5,000 enrolled1 locationNCT05318196
Recruiting
Early Phase 1

A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases

Relapsed/Refractory Autoimmune Diseases
Beijing Boren Hospital18 enrolled1 locationNCT07448298
Recruiting
Phase 1Phase 2

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting
Phase 1Phase 2

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases

Autoimmune Diseases
Beijing GoBroad Hospital18 enrolled1 locationNCT06688799
Recruiting
Not Applicable

Exploratory Clinical Study on the Safety of STR-P004

Autoimmune Diseases
Beijing GoBroad Hospital39 enrolled1 locationNCT07143617
Recruiting
Early Phase 1

A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

Neurological Autoimmune Diseases
Juventas Cell Therapy Ltd.18 enrolled1 locationNCT07275736